About Journal

P-ISSN 2587-2400 | E-ISSN 2587-196X

Aims and Scope
Aim of the journal is to publish qualified research material on its scope. The target readership includes academic members or specialists on medicine and oncology. Scope of the journal covers medicine and oncology.
EJMO publishes articles following a double-blind peer review mechanism to ensure the standards of its publications.
EJMO selects generally from Reviewers situated in ScholarOne-Publons. The Eurasian Journal of Medicine and Oncology (EJMO) is published every three months (March, June, September, December)

Abstracting and Indexing
EJMO has been indexed in Emerging Sources Citation Index (web of science) (ESCI)
EJMO is being evaluated by SCOPUS
EJMO has been indexed in EBSCO Since November 2020
EJMO has been indexed in ProQuest Since 2020
EJMO has been indexed in TUBITAK TR Index since 2019
TUBITAK is an institution of Republic Of Turkey Ministry of Industry and Technology
EJMO has been indexed in Index Copernicus Journal Master List since 2017
EJMO has been indexed in Turkish Medline National Health Sciences Periodicals Database since 2018

Abbreviation
Eurasian J Med Oncol

Publication Fees
There is no fee for article submission, article processing or publication.

Revenue sources
Revenue source only of EJMO journal consist of advertisements of institutional pharmaceutical companies that are only available in the print version.
There is a printed version of each issue.
Companies that advertise in printed version in 2020 of Journal ; AMGEN, PFIZER, BRISTOL MYERS SQUIBB, MERCK, NOVARTIS, ROCHE, ASTELLAS, ASTRAZENECA, JOHNSON & JOHNSON, NOBEL, OMNIGEN, ARVEN, TEVA, MUSTAFA NEVZAT and TR PHARM

Digital archiving and preservation policy
If journal stops publishing : We intend and expect to continue to publish our journal for a very long time. If, due to some rare, unfortunate circumstances, we are forced to stop publishing the journal, the manuscripts published in the journal will be kept online and accessible to the readers through TUBITAK (TUBITAK is an institution of Republic Of Turkey Ministry of Industry and Technology) and Turkish Medline National Health Sciences Periodicals Database http://www.turkmedline.net/degilistesi.php?journal=562

Basic Publication Rules
Authors are responsible for the accuracy of data and the journal is in compliance with the uniform requirements for manuscripts submitted to biomedical journals published by the ICMJE. The editorial and publication processes of the journal are conducted in accordance with the guidelines of the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the European Association of Science Editors (EASE), and the Committee on Publication Ethics (COPE) as well.

Basic Language Rules
If you are author not a native English speaker, we recommend that you have your manuscript professionally edited before submission or read by a native English-speaking colleague. we recommend that you get this service from https://www.scribendi.com/service/academic_proofreading

Disclaimer
Statements or opinions expressed in the manuscripts published in Eurasian Journal of Medicine and Oncology reflect the views of the author(s) and not the opinions of the editors, the editorial board and the publisher; the editors, the editorial board and the publisher disclaim any responsibility or liability for such materials.

Access to Journal Content
The abstracts and full texts of published articles can be accessed free of charge at www.ejmo.org www.ejmo.org

Editor

Owners-Contact

Oncology and Immunotherapy Association is a partner to EJMO

Publisher